期刊
DATA IN BRIEF
卷 45, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.dib.2022.108683
关键词
Prostatic neoplasms; Multiparametric magnetic resonance; imaging; Imaging guided biopsy; Pathology
This data article retrospectively analyzed the effectiveness of magnetic resonance imaging/ultrasound-guided biopsy in detecting clinically significant prostate cancer based on a sample collective of 785 patients.
This is a data article from the original publication Rea-sons for missing clinically significant prostate cancer by tar-geted magnetic resonance imaging/ultrasound fusion-guided biopsy [1] . From January 2014 to April 2019 a sample collec-tive of 785 patients with 3T multiparametric magnetic res-onance imaging (mp-MRI) of the prostate and subsequent combined systematic biopsy (SB) and magnetic resonance imaging/ultrasound (US) fusion-guided biopsy (TB) was ret-rospectively analyzed. Prostate cancer (PCa) detection by TB and/or additional SB was analyzed.(c) 2022 The Authors. Published by Elsevier Inc.This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据